Pay in 4 interest-free payments of $5.02 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
PubMed , Cell Metabolism , vol
This, in turn, can narrow the arteries, leading to reduced blood flow
250 HoffmannPRJourdan-Le SauxCHoffmannFWChangPSBolltOHeQet al
In contrast, Ultomiris failed to significantly improve event-free survival over placebo in adults and adolescents with HSCT-TMA, marking the latest setback for AstraZeneca's pipeline after a failed heart disease trial earlier this month and an FDA advisory committee voted against approving its breast cancer therapy in May
therapeutic potentials
US$ 27.94
US$ 21.84
US$ 20.15
US$ 22.17
US$ 22.75
